22-30932942-C-G

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_001303256.3(MORC2):​c.2469G>C​(p.Arg823Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00733 in 1,614,190 control chromosomes in the GnomAD database, including 80 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. R823R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0048 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0076 ( 79 hom. )

Consequence

MORC2
NM_001303256.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.289

Publications

3 publications found
Variant links:
Genes affected
MORC2 (HGNC:23573): (MORC family CW-type zinc finger 2) This gene encodes a member of the Microrchidia (MORC) protein superfamily. The encoded protein is known to regulate the condensation of heterochromatin in response to DNA damage and play a role in repressing transcription. The protein has been found to regulate the activity of ATP citrate lyase via specific interaction with this enzyme in the cytosol of lipogenic breast cancer cells. The protein also plays a role in lipogenesis and adipocyte differentiation. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2016]
MORC2 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease axonal type 2Z
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)
  • developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Leigh syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BP6
Variant 22-30932942-C-G is Benign according to our data. Variant chr22-30932942-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 475582.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.289 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00482 (734/152310) while in subpopulation SAS AF = 0.0139 (67/4832). AF 95% confidence interval is 0.0112. There are 1 homozygotes in GnomAd4. There are 360 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 734 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MORC2NM_001303256.3 linkc.2469G>C p.Arg823Arg synonymous_variant Exon 22 of 26 ENST00000397641.8 NP_001290185.1 Q9Y6X9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MORC2ENST00000397641.8 linkc.2469G>C p.Arg823Arg synonymous_variant Exon 22 of 26 5 NM_001303256.3 ENSP00000380763.2 Q9Y6X9-1

Frequencies

GnomAD3 genomes
AF:
0.00482
AC:
733
AN:
152192
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00104
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00249
Gnomad ASJ
AF:
0.00605
Gnomad EAS
AF:
0.00116
Gnomad SAS
AF:
0.0136
Gnomad FIN
AF:
0.00273
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00760
Gnomad OTH
AF:
0.00382
GnomAD2 exomes
AF:
0.00686
AC:
1725
AN:
251462
AF XY:
0.00735
show subpopulations
Gnomad AFR exome
AF:
0.00123
Gnomad AMR exome
AF:
0.00359
Gnomad ASJ exome
AF:
0.00496
Gnomad EAS exome
AF:
0.000924
Gnomad FIN exome
AF:
0.00291
Gnomad NFE exome
AF:
0.00834
Gnomad OTH exome
AF:
0.00652
GnomAD4 exome
AF:
0.00759
AC:
11100
AN:
1461880
Hom.:
79
Cov.:
31
AF XY:
0.00790
AC XY:
5747
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.00114
AC:
38
AN:
33480
American (AMR)
AF:
0.00367
AC:
164
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00490
AC:
128
AN:
26134
East Asian (EAS)
AF:
0.000756
AC:
30
AN:
39700
South Asian (SAS)
AF:
0.0147
AC:
1266
AN:
86258
European-Finnish (FIN)
AF:
0.00303
AC:
162
AN:
53416
Middle Eastern (MID)
AF:
0.0205
AC:
118
AN:
5768
European-Non Finnish (NFE)
AF:
0.00790
AC:
8784
AN:
1112006
Other (OTH)
AF:
0.00679
AC:
410
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
691
1381
2072
2762
3453
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
336
672
1008
1344
1680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00482
AC:
734
AN:
152310
Hom.:
1
Cov.:
33
AF XY:
0.00483
AC XY:
360
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.00103
AC:
43
AN:
41560
American (AMR)
AF:
0.00248
AC:
38
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00605
AC:
21
AN:
3470
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5174
South Asian (SAS)
AF:
0.0139
AC:
67
AN:
4832
European-Finnish (FIN)
AF:
0.00273
AC:
29
AN:
10628
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.00760
AC:
517
AN:
68018
Other (OTH)
AF:
0.00378
AC:
8
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
39
79
118
158
197
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00647
Hom.:
1
Bravo
AF:
0.00458
Asia WGS
AF:
0.00520
AC:
18
AN:
3478
EpiCase
AF:
0.00758
EpiControl
AF:
0.00800

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MORC2: BP4, BP7, BS1, BS2 -

Oct 09, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 24, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Charcot-Marie-Tooth disease axonal type 2Z Benign:2
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.37
CADD
Benign
6.6
DANN
Benign
0.79
PhyloP100
0.29
PromoterAI
-0.0035
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41279971; hg19: chr22-31328929; API